Clinical trial
Mirapex PMS Study Final Report
NCT02248168 is registered in ClinicalTrials.gov with Boehringer Ingelheim as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Mirapex PMS Study Final Report
- Lead sponsor
- Boehringer Ingelheim
- Phase
- Observational
- Overall status
- Completed
- Start date
- March 31, 2002
- Completion date
- Not reported
- Enrollment
- 1,449 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.